###### Strengths and limitations of this study

-   The first prospective study to explore the association between Meniere's disease (MD) and retinal vascular calibre in China.

-   The healthy controls were matched for sex, age and vascular risk factors to potentially reduce the effect of confounding factors.

-   There is the potential for recall bias as MD and migraine were always diagnosed based on clinical symptoms.

-   Single-centre study that included a limited number of patients.

Introduction {#s1}
============

Since Meniere's disease (MD) was described by Prosper Meniere in 1861, it has been regarded as a chronic illness that affects a large number of patients worldwide every year.[@R1] Studies conducted in Finland, Italy, UK and the USA have estimated the prevalence of MD to be 0.043%, 0.086%, 0.51% and 0.22%, respectively.[@R2] MD is characterised by paroxysmal vertigo lasting from minutes to hours, accompanied by fluctuating hearing loss, tinnitus and aural pressure. Although many studies have proven that the primary histopathological substrate is endolymphatic hydrops (EH), the real pathological mechanism remains unclear.[@R7] At present, it is believed that MD is a disease of unknown aetiology with multiple contributing factors, including family history, viral infection, allergy and autoimmunity. EH is considered a necessary but insufficient factor for the progression of MD.[@R8] Though some studies suggest that the occurrence and progression of MD is closely related to vascular disorders, these studies are relatively few.[@R7]

Large studies have reported that MD can coexist with migraines and suggest that there is a close pathophysiological relationship between these two disorders.[@R9] Migraines occur more commonly in patients with MD than in the general population, which seems to support the concept that the disorders share a common pathophysiological process.[@R11] In fact, several scholars have regarded migraine as an additional symptom in typical MD attacks. Although the pathogenesis of migraine is still debated, there seems to be an association with the neurovascular system.[@R12] Retinal vascular disorder has been reported in patients with migraine and is thought to result from activation of the trigeminal vascular system (TVS), which innervates the blood vessels of the eyes.[@R13] It has been demonstrated that the inner ear blood flow is also directly affected by the trigeminal nerve through innervation of cochlear vasculature.[@R14] We therefore hypothesised that retinal vascular disorders may exist in patients with MD due to the close relationship between MD and migraine.

The retina has been regarded as a unique site where the microvasculature can be visualised and observed directly in vivo.[@R17] Retinal photographic imaging techniques can accurately measure and quantify subtle abnormalities and changes in the retinal microvasculature. Several researchers have previously reported that branch retinal artery occlusion and retinal perivasculitis occur in patients with MD.[@R18] In this study, we examined our hypothesis and the association between MD and retinal vascular calibre. The aim of our study was (1) to evaluate and compare retinal vascular calibres between patients with MD and healthy subjects matched for age, sex and vascular risk factors using retinal photographs and (2) to compare the clinical characteristics and retinal vascular calibres between patients with MD alone and those with migraines.

Methods {#s2}
=======

Study design {#s2a}
------------

We conducted a prospective, observational study. Based on the presence of migraine, studied patients with MD were divided into two groups: patients with MD alone and those with migraine. The diagnosis of MD and migraine was made on the basis of the criteria defined by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and International Headache Society (IHS).[@R20] The study contained two parts. (1) We evaluated and compared retinal vascular calibres between patients with MD alone and healthy subjects matched for age, sex and vascular factors to determine whether there was an association between MD and retinal vascular calibres. (2) We compared the clinical characteristics and retinal vascular calibres between patients with MD alone and those with migraine.

Patients {#s2b}
--------

Studied patients were enrolled in the Otolaryngologic Department in Peking University People's Hospital between 1 June 2014 and 1 January 2016. Patients aged 20--70 years old were eligible for enrolment if they complained mainly about two or more spontaneous episodes of vertigo lasting from 20 min to 12 hours within the past several years. Those vertigo patients who were diagnosed with MD according to AAO-HNS ([box 1](#B1){ref-type="boxed-text"}) were included in this study.[@R20] All patients underwent many imaging examinations such as CT and MRI to exclude acoustic neuroma and to make a diagnosis of EH. The control group consisted of 62 healthy subjects matched for age, sex and vascular risk factors. These healthy subjects had no complaints of symptoms of hearing loss or vertigo attacks and had not been previously diagnosed with either MD or migraine. Key exclusion criteria included having a history of ocular surgery influencing the examination of the fundus, current or a history of hypertension and diabetes that affected the retinal vascular calibre, current ocular inflammation, glaucoma or other diseases that could alter the calibre of blood vessels, autoimmune diseases, smoking history and ischaemic heart disease. We also excluded patients who had other peripheral vertigo such as vestibular migraine (VM) alone, benign paroxysmal positional vertigo, central vertigo, psychogenic vertigo and vertigo caused by systemic disease.Box 1Diagnosis of Meniere's diseaseCertain Meniere's diseaseDefinite Meniere's disease, plus histopathological confirmationDefinite Meniere's diseaseTwo or more definitive spontaneous episodes of vertigo 20 min or longerAudiometrically documented hearing loss on at least one occasionTinnitus or aural fullness in the treated earOther causes excludedProbable Meniere's diseaseOne definitive episode of vertigoAudiometrically documented hearing loss on at least one occasionTinnitus or aural fullness in the treated earOther causes excludedPossible Meniere's diseaseEpisodic vertigo of the Meniere type without documented hearing loss, orSensorineural hearing loss, fluctuating or fixed, with dysequilibrium but without definitive episodesOther causes excluded

Because of the similarities in the clinical features between MD and VM and because there are no examinations available to adequately distinguish the two disorders, many studies have suggested that a history of progressive hearing loss is sensitive and specific for MD. Ultimately, we chose to regard the symptom of progressive hearing loss as a criteria for separating MD and VM.

Several professors skilled in treating vertigo reviewed our data and concluded that our study diagnoses were based on the AAO-HNS definition of MD, third edition of the International Classification of Headache Disorders (ICHD-III) criteria for migraine and VM.[@R20] These diagnoses were not mutually exclusive, and patients could be diagnosed with MD with migraine or MD with VM when they met the diagnostic criteria for both diseases. We put MD with VM in the category of MD with migraine because VM is a special type of migraine according to ICHD-III.[@R21] The study was approved by the hospital's ethics committee. All the patients provided written informed consent.

We collected detailed information about demographic and clinical characteristics including age and sex, course of MD, duration and frequency of vertigo attacks, tinnitus and aural fullness (yes or no), photophobia and phonophobia (yes or no) and visual aura (yes or no). Some studies reported a close association between retinal vascular calibres and vascular risk factors such as systolic pressure, diastolic pressure, blood glucose, serum triglycerides, cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels. We measured and matched these risk factors between studied patients and healthy controls to decrease the impact of these confounding variables on retinal vascular calibres. In addition, pure tone hearing tests of all patients had been performed many times in the past.

Measurement of retinal vascular calibre {#s2c}
---------------------------------------

Retinal photography under cycloplegia was performed on all patients with MD and control subjects. Retinal colour images (resolution 2048×2048 pixels) were acquired at a 30° angle with the optic nerve head centred by using the Canon CX-1 Fundus camera (Canon, Japan). The measurement of retinal vascular calibres was taken on disc-centred photographs with the use of computer-assisted software (Canon, Japan). Artery:vein ratio (AVR), central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE) were obtained by using arterial and venous diameters. Arteries and veins located within the area of one-half disc diameter (DD) to one full DD from the optic disc margin were selected for measurements (AVR, CRAE and CRVE) ([figure 1](#F1){ref-type="fig"}). These measurements were used for describing the physical structure of different retinal arteries and veins such as luminal calibre. The detailed definitions and measurement methods for each retinal vascular parameter are previously explained elsewhere.[@R22] In a past study, we compared the retinal vascular calibre between both eyes of patients with unilateral MD and found that the retinal vascular calibre on the side of the affected ear was significantly larger than that on the contralateral side. Therefore, in this study, all vessels were measured in the eye that was on the same side as the affected ear in patients with unilateral MD, but the vessels of the eye on the same side of the more seriously affected ear were measured in patients with bilateral MD.

![Representative image showing retinal vascular calibre measurement used in this study. Zone B: 0.5--1.0 disc diameters from the disc margin. Red line: artery tracking. Blue line: vein tracking.](bmjopen-2018-022069f01){#F1}

Patient and public involvement {#s2d}
------------------------------

No patients were involved in the development and design of the study.

Statistical analysis {#s2e}
--------------------

SPSS software (V.21.0, SPSS) was used for statistical analyses. For categorical data, frequencies and percentages were calculated to describe the distributions of subgroups among patients according to sex, disease course, duration and frequency of vertigo attacks, photophobia, phonophobia and visual aura. Categorical data were compared using χ^2^ or Fisher exact tests if appropriate. Means (±SD) were used to summarise the average levels of quantitative data such as age, body mass index, retinal vascular calibres and vascular risk factors. A Shapiro-Wilk test was used for examining whether the measured values were in accordance with a normal distribution. At eye measurement level, the data of retinal vascular calibres that were distributed normally were compared by two-sample t-test between patients with MD and healthy controls, and between patients with MD alone and those with migraine.

Generalised linear regression analysis, in which age, sex, duration of MD, frequency of vertigo attacks and migraine symptoms were included as covariates, was used to assess the correlation of these independent factors with the retinal calibres among patients with MD. The linear regression analysis contained two models, an unadjusted analysis model and an adjusted analysis model that was adjusted for age and sex. Beta coefficient and 95% CI were calculated according to model-variable coefficients and SE, respectively. All p values of less than 0.05 were considered to indicate statistical significance.

Results {#s3}
=======

Demographic characteristics {#s3a}
---------------------------

In all, 60 patients with MD were enrolled out of 76 subjects (the other 16 patients were excluded from this study based on the exclusion criteria): 31 female patients (51.7%) and 29 male patients (48.3%). The mean age of the patients with MD and healthy controls was 53.58±10.74 and 53.32±10.46, respectively. According to the IHS criterion, 24 patients with MD had migraine, and 36 patients with MD did not have migraine. Demographic characteristics and vascular risk factors of patients with MD alone and matched healthy controls are shown in [table 1](#T1){ref-type="table"}.

###### 

Demographic characteristics and vascular risk factor levels in studied patients with MD and healthy controls

                                       MD patients    Healthy controls   P values
  ------------------------------------ -------------- ------------------ ----------
  Age (years)                          53.58±10.74    53.32±10.46        0.89
  Women (%)                            31 (51.7)      32 (51.6)          0.85
  BMI (scores)                         24.37±3.43     24.54±3.45         0.78
  Current systolic pressure (mm Hg)    122.83±14.05   120.63±10.66       0.31
  Current diastolic pressure (mm Hg)   80.18±8.48     78.74±7.19         0.29
  Blood glucose                        5.77±1.16      5.60±0.75          0.31
  Triglyceride (mmol/L)                1.51±1.20      1.44±1.25          0.75
  Cholesterol (mmol/L)                 4.91±0.87      4.85±0.80          0.69
  HDL-C (mmol/L)                       1.18±035       1.17±0.33          0.54
  LDL-C (mmol/L)                       2.97±0.75      2.94±0.68          0.87

BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MD, Meniere's disease.

Clinical characteristics {#s3b}
------------------------

All patients with MD had vertigo attacks and tinnitus, while most patients with MD had aural fullness (76.7%). MD patients with migraine had more frequent vertigo attacks than patients with MD alone. The frequency of vertigo attacks in a week was 41.7% for MD patients with migraine and 13.9% for MD patients without migraine (P=0.015). MD patients with migraine experienced a longer duration of vertigo attacks than those without migraine (with an interval of \>6 hours for 37.5% MD patients with migraine and for 8.3% MD patients without migraine, p=0.006). Compared with patients with MD alone, more MD patients with migraine complained of symptoms of phonophobia (75.0% vs 25.0%, p=0.004) and visual aura (29.2% vs 8.3%, p=0.034) ([table 2](#T2){ref-type="table"}).

###### 

The clinical characteristics of all 60 patients with MD

                                          MD patients with migraine   Patients with MD alone   All patients with MD   P values
  --------------------------------------- --------------------------- ------------------------ ---------------------- ----------
  Disease course (no. (%))                                                                                            
   \<1/2 year                             3 (12.5)                    8 (22.2)                 11 (18.3)              0.340
   1/2--1 year                            2 (8.3)                     6 (16.7)                 8 (13.3)               0.352
   1--10 years                            17 (70.8)                   18 (50.0)                35 (58.3)              0.109
   \>10 years                             2 (8.3)                     4 (11.1)                 6 (10.0)               0.725
  Duration of vertigo attacks (no. (%))                                                                               
   \<1 hour                               7 (29.2)                    14 (38.9)                21 (35.0)              0.439
   1--6 hours                             8 (33.3)                    19 (52.8)                27 (45.0)              0.138
   \>6 hours                              9 (37.5)                    3 (8.3)                  12 (20.0)              0.006
  Frequency of vertigo (no. (%))                                                                                      
   \<1 week                               10 (41.7)                   5 (13.9)                 15 (25.0)              0.015
   1 week--1month                         5 (20.8)                    13 (36.1)                18 (30.0)              0.206
   1 month--6 months                      5 (20.8)                    10 (27.8)                15 (25.0)              0.543
   6 months--1 year                       4 (16.7)                    6 (16.7)                 10 (16.7)              0.990
   \>1 year                               0 (0)                       2 (5.6)                  2 (3.3)                0.240
  Photophobia (no. (%))                   10 (41.7)                   15 (41.7)                25 (41.7)              0.990
  Phonophobia (no. (%))                   18 (75.0)                   9 (25.0)                 27 (45.0)              0.001
  Visual aura (no. (%))                   7 (29.2)                    3 (8.3)                  10 (16.7)              0.034
  Tinnitus (no. (%))                      24 (82.8)                   36 (92.3)                60 (88.2)              0.227
  Aura fullness (no. (%))                 20 (83.3)                   26 (72.2)                46 (76.7)              0.319
  Stage of MD (no. (%))                   0.899                                                                       
   Stage 1                                2 (8.3)                     4 (10.3)                 6 (10.0)               
   Stage 2                                4 (16.7)                    4 (10.3)                 8 (13.3)               
   Stage 3                                14 (58.3)                   23 (63.9)                37 (61.7)              
   Stage 4                                4 (16.7)                    5 (13.9)                 9 (15.0)               

Calculated p values were made for comparison between subgroups of patients with MD.

MD, Meniere's disease.

Eye measurement {#s3c}
---------------

Compared with healthy controls, patients with MD exhibited larger arteries (126.30±10.45 vs 119.61±15.86, p=0.006) and a higher retinal AVR (0.79±0.09 vs 0.75±0.10, p=0.005) ([table 3](#T3){ref-type="table"}). For patients with MD, the CRAE was larger in those with migraine than in patients with MD alone (130.73±11.55 vs 123.35±8.61, p=0.006), but AVR did not differ significantly between subgroups of patients with MD ([table 4](#T4){ref-type="table"}). The CRVE did not differ significantly either between patients with MD and healthy controls or between subgroups between patients with MD. We set a type Ⅰ error probability of 0.05 and calculated a power for this two-sample means test of 0.82 (larger than 0.80), which is sufficient for determining the significant difference between patients with MD and controls.

###### 

Comparison of retinal vascular calibres between patients with MD and matched healthy controls

  Variable    Patients with MD   Healthy controls   P values
  ----------- ------------------ ------------------ ----------
  CRAE (µm)   126.30±10.45       119.61±15.86       0.006
  CRVE (µm)   159.85±10.35       161.04±10.41       0.516
  AVR (µm)    0.79±0.09          0.75±0.10          0.005

Calculated p values were made for comparison between the group of patients with MD and control group.

AVR, artery:vein ratio; CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent; MD, Meniere's disease.

###### 

Comparison of retinal vascular calibres between subgroups of patients with MD

  Variable    MD patients with migraine   Patients with MD alone   All patients with MD   P values
  ----------- --------------------------- ------------------------ ---------------------- ----------
  CRAE (µm)   130.73±11.55                123.35±8.61              126.30±10.45           0.006
  CRVE (µm)   160.32±9.11                 159.54±11.22             159.85±10.35           0.778
  AVR (µm)    0.82±0.09                   0.78±0.09                0.79±0.09              0.083

Calculated p values were made for comparison between subgroups of patients with MD.

AVR, artery:vein ratio; CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent; MD, Meniere's disease.

Factors correlated with retinal vascular calibre {#s3d}
------------------------------------------------

We considered sex, age, frequency of vertigo attacks, symptoms of migraine and duration of vertigo attacks as potential factors correlated with retinal vascular calibre in patients with MD. In our study, age and sex were not significantly correlated with retinal vascular calibre; however, the CRVE was inversely correlated with the duration of vertigo attacks (adjusted beta coefficient, −2.22; 95% CI, −7.51 to −0.41; p=0.014); the CRAE was positively correlated with the presence of migraine (adjusted beta coefficient, 3.19; 95% CI, 1.44 to 6.03; p=0.001) and frequency of vertigo attacks (adjusted beta coefficient, 2.36; 95% CI, 1.12 to 12.16; p=0.018) ([table 5](#T5){ref-type="table"}).

###### 

Multivariate relationship between retinal vascular calibre and covariates within patients with MD

                                 Adjusted analysis      Unadjusted analysis                                                                                          
  ------------------------------ ---------------------- --------------------- ----------------------- ------- ---------------------- ------- ----------------------- -------
  Age                            --                     --                    --                      --      0.39 (−0.21 to 0.30)   0.694   −0.62 (−0.33 to 0.17)   0.534
  Female                         --                     --                    --                      --      1.62 (−0.91 to 9.67)   0.105   0.90 (−2.88 to 7.76)    0.369
  Duration of vertigo attacks    0.77 (−2.21 to 5.08)   0.441                 −2.22 (−7.51 to 0.47)   0.014   0.90 (−1.98 to 5.32)   0.370   −2.15 (−7.34 to 0.34)   0.032
  Frequency of vertigo attacks   3.19 (1.44 to 6.03)    0.001                 −0.30 (−2.88 to 2.11)   0.761   3.27 (1.54 to 6.12)    0.001   −0.22 (−2.75 to 2.19)   0.824
  Migraine                       2.36 (1.12 to 12.16)   0.018                 0.03 (−5.71 to 5.87)    0.979   2.83 (2.27 to 12.48)   0.28    0.28 (−4.61 to 6.17)    0.78

Age and sex were adjusted in the adjusted model.

AVR, artery:vein ratio; CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent; MD, Meniere's disease.

Discussion {#s4}
==========

In this prospective study evaluating the association between MD and retinal vascular calibres, generalised linear regression analysis revealed that the presence of migraine and the frequency of vertigo attacks appear to increase the retinal artery calibre in patients with MD. The results indicated that MD patients with migraine presented with more frequent vertigo attacks, longer duration of vertigo attacks and a larger retinal artery than patients with MD alone. This finding contrasts with those of Gerald *et al* [@R24] who reported that the mean retinal arteriolar diameter was slightly smaller in subjects with a history of any migraine, but did not differ significantly from those without a history of any migraine. Our results suggest that screening for the presence of migraine in patients with MD could be based not only on the frequency and duration of vertigo attacks but also on the measurement of retinal artery calibre.

Several studies have demonstrated a relationship between MD and retinal blood vessels. Recupero SM *et al* described a young patient with MD who was affected by branch retinal artery occlusion and migraine headaches.[@R19] Wanger *et al* presumed that retinal perivasculitis was associated with MD and reported that a common pathogenetic mechanism of microvasculopathy resulted in a parallel clinical course and simultaneous therapeutic response to corticosteroids.[@R18] In our analysis of retinal vascular calibre in patients with MD and matched healthy subjects, the CRAE and AVR were larger in patients with MD. Our results suggest there is a close relationship between MD and retinal artery calibre and, furthermore, that the retinal artery calibre could increase in patients with MD.

Some studies have previously reported an association between MD and glaucoma, but the results have always been inconsistent. Setch *et al* evaluated the audiovestibular function in patients with glaucoma and found a cochlear lesion in these patients.[@R25] However, many studies have indicated there was no relationship between MD and glaucoma. Berkowitz *et al* reported that none of the 10 patients with idiopathic EH had glaucoma. Shapiro *et al* found no association between glaucoma and hearing loss when evaluating the hearing thresholds of 67 patients with bilateral function.[@R26] Kabudwabd *et al* also showed no evidence of a relationship between glaucoma and inner ear hearing loss, but considered that EH can appear together with glaucoma on the basis of the hypothesis that EH in an early stage may be present without hearing loss.[@R27]

In our study, 24 of 60 patients with MD (40.0%) had a history of or current migraine, a finding that is consistent with many scholars who have reported that MD can coexist with migraine as defined by the IHS.[@R9] MD patients with migraine had more frequent vertigo attacks than those without migraine (with an interval of \<1 week, 41.7% vs 13.9%, p=0.015). The incidence of frequent vertigo attacks (with an interval of \<1 week) in MD patients with migraine was slightly lower than those in the study by Morganti *et al*,[@R28] who reported that 67.6% of VM patients had more than one incidence of vertigo attacks within a week. Moreover, a greater number of MD patients with migraine had a long duration of vertigo attacks compared with those without migraine (37.5% vs 8.3%, p=0.006). Since MD patients with migraine had more frequent and longer lasting vertigo attacks than those without migraine, the frequency and duration of vertigo attacks may be useful for screening for the presence of migraine in patients with MD. The main histopathology of MD is EH, and the outflow of hydrops can cause vertigo attacks.[@R1] However, the vestibulo-thalamo-cortical pathway is always increasingly active in patients with migraine, and the degree of thalamic activation is intimately related to the frequency of migraine and vertigo attacks.[@R30] We hypothesise that because EH from formation to outflow develops over a certain period of time, the vertigo cannot occur many times within a short period of time in patients with MD alone. However, in MD patients with migraine, vertigo attacks may involve both migrainous vertigo and Meniere's vertigo. In this case, not only the outflow of hydrops but also stimuli activating the thalamus can lead to vertigo attacks.

In our analysis of retinal vascular calibre between patients with MD alone and MD patients with migraine, MD patients with migraine had slightly larger CRAE than patients with MD alone. Although some studies have previously described the retinal vascular calibre in patients with migraine, the results have not always been unanimous. Gasser *et al* reported that the retinal vascular calibre did not differ significantly between patients with migraine and controls.[@R33] Liew *et al* analysed retinal photographs of 1970 subjects aged 49 to 97 years and found that the retinal arterioles were slightly narrower in subjects with migraine than those without migraine, but the venular diameter did not differ between subjects.[@R24] In a recent study, Unlu *et al* compared the retinal vessel diameters between patients with migraine and control subjects matched for age and sex and discovered that patients with ≥5 migraine attacks per month had a larger retinal artery than the control group.[@R34] Asghar *et al* also reported that the migraine attacks were associated with dilatation of both extracranial and intracranial vessel.[@R35]

There are several potential explanations for our findings. It is widely accepted that the activity and sensitisation of the TVS can cause headache. The active and sensitive TVS leads to the release of vasoactive neuropeptides from their perivascular endings, mainly through the ophthalmic division of the trigeminal nerve.[@R36] It has been confirmed that the ophthalmic branch of TVS innervates the blood flow in both the retina and cochlea.[@R8] These vasoactive neuropeptides including substance P(SP), calcitonin gene-related peptide and neurokinin A cause vasodilation, increased cerebral blood flow, extravasation of plasma protein, release of proinflammatory factors and finally neurogenic inflammation.[@R36] We hypothesise that when migraine attacks occur, the release of vasoactive neuropeptides can cause neurogenic inflammation and dilation of retinal blood vessels and the cochlear vasculature, which may aggravate EH and accelerate the outflow of EH. This may be a potential relationship between MD and migraine, and another reason why MD patients with migraine have frequent attacks. The larger artery calibre in MD patients with migraine compared with patients with MD alone may result from the release of vasoactive neuropeptides during headache, and the frequent release of these vasodilators may cause permanent structural changes in blood vessels.

Froster *et al* reviewed 3707 temporal bones with EH and found that only 165 cases could be diagnosed with MD according to the AAO-HNS 1995 criteria.[@R37] Gurkov *et al* concluded that EH is necessary but not sufficient for the development of MD.[@R38] Most animal experiments have demonstrated that MD attacks cannot be caused by a model of EH, though they can triggered by altered vascular flow in the inner ear.[@R39] Our conjecture is that migraine is a type of vascular disorder that can alter the vascular flow in the inner ear and lead to MD attacks in patients with EH.

Our study has several limitations. First, this is a prospective, single-centre study with a limited number of patients. Second, because MD and migraine were always diagnosed based on clinical symptoms, there is a potential for recall bias. Third, patients were first treated in other hospitals, especially those who had symptoms of migraine, and may have come to our hospital for further treatment. Thus, there exists a potential for both a referral bias and a potential overestimation of the incidence of migraine in patients with MD. Finally, no single clinical characteristic or examination is specific for a diagnosis of MD, which is based on the clinical criteria alone. Thus, there is always the potential for diagnostic error.

Conclusions {#s5}
===========

Our study indicates that a relationship exists between MD and retinal vascular calibre. Patients with MD had a slightly larger artery calibre than matched healthy controls. Increased retinal artery calibre was associated with migraine and a high frequency of vertigo attacks in patients with MD patients. We suggest that symptoms of migraine should be considered part of the standard of the classification of MD. MD was divided into two types, MD alone and MD without migraine. MD patients with migraine experienced more frequent vertigo attacks and had a larger artery calibre than patients with MD alone. More MD patients with migraine also complained of a long duration of vertigo attacks, phonophobia and visual aura. Taken together, these findings support the existence of a close pathophysiological relationship between migraine and MD attacks. Prophylactic therapy for migraine may therefore contribute to the prevention of MD attacks in MD patients with migraine. More extensive studies are required to explore the association between retinal vascular calibre and MD.
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